{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:40:29Z","timestamp":1790617229335,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"\u201cFunda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia\u201d (FCT), Portugal","award":["PTDC\/SAU-FCF\/66421\/2006"],"award-info":[{"award-number":["PTDC\/SAU-FCF\/66421\/2006"]}]},{"name":"\u201cFunda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia\u201d (FCT), Portugal","award":["PTDC\/SAU-FCF\/108056\/2008"],"award-info":[{"award-number":["PTDC\/SAU-FCF\/108056\/2008"]}]},{"name":"COMPETE-\u201cPrograma Operacional Factores de Competitividade\u201d, QREN"},{"name":"European Union (FEDER-\u201cFundo Europeu de Desenvolvimento Regional\u201d)"},{"DOI":"10.13039\/100003950","name":"CNC","doi-asserted-by":"publisher","award":["PEst-C\/SAU\/LA0001\/2013-2014"],"award-info":[{"award-number":["PEst-C\/SAU\/LA0001\/2013-2014"]}],"id":[{"id":"10.13039\/100003950","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ph.D. fellowships","award":["SFRH\/BD\/86655\/2012"],"award-info":[{"award-number":["SFRH\/BD\/86655\/2012"]}]},{"name":"Ph.D. fellowships","award":["SFRH\/BD\/41285\/899\/2007"],"award-info":[{"award-number":["SFRH\/BD\/41285\/899\/2007"]}]},{"name":"Ph.D. fellowships","award":["SFRH\/BD\/51192\/2010"],"award-info":[{"award-number":["SFRH\/BD\/51192\/2010"]}]},{"name":"postdoctoral fellowships","award":["SFRH\/BPD\/26872\/2006"],"award-info":[{"award-number":["SFRH\/BPD\/26872\/2006"]}]},{"name":"postdoctoral fellowships","award":["SFRH\/BPD\/44246\/2008"],"award-info":[{"award-number":["SFRH\/BPD\/44246\/2008"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","neuropeptidesjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.npep.2016.01.009","type":"journal-article","created":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T02:00:20Z","timestamp":1454464820000},"page":"73-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin"],"prefix":"10.1016","volume":"58","author":[{"given":"Luana","family":"Naia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcio","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana R.","family":"Rosenstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0700-3776","authenticated-orcid":false,"given":"A. Cristina","family":"Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2016.01.009_bb0005","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1006\/nbdi.2002.0562","article-title":"Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression","volume":"11","author":"Andreassen","year":"2002","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.npep.2016.01.009_bb0010","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1471-4159.1986.tb04539.x","article-title":"Changes in nine enzyme markers for neurons, glia, and endothelial cells in agonal state and Huntington's disease caudate nucleus","volume":"47","author":"Butterworth","year":"1986","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2016.01.009_bb0015","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nm1202-793","article-title":"Serum insulin-like growth factor I regulates brain amyloid-beta levels","volume":"8","author":"Carro","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.npep.2016.01.009_bb0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0022-510X(84)90138-2","article-title":"Increased alanine aminotransferase activity in the Huntington's disease putamen","volume":"66","author":"Carter","year":"1984","journal-title":"J. Neurol. Sci."},{"issue":"5793","key":"10.1016\/j.npep.2016.01.009_bb0025","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1126\/science.1124646","article-title":"Opposing activities protect against age-onset proteotoxicity","volume":"313","author":"Cohen","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.npep.2016.01.009_bb0030","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1046\/j.1471-4159.2003.01706.x","article-title":"Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice","volume":"85","author":"Dedeoglu","year":"2002","journal-title":"J. Neurochem."},{"issue":"2\u20133","key":"10.1016\/j.npep.2016.01.009_bb0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1054\/npep.2002.0893","article-title":"Mutant mouse models of insulin-like growth factor actions in the central nervous system","volume":"36","author":"D'Ercole","year":"2002","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2016.01.009_bb0040","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.bbamcr.2008.02.016","article-title":"Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3\u03b2 signaling pathways and changes in protein expression","volume":"1783","author":"Duarte","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.npep.2016.01.009_bb0045","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.expneurol.2011.06.016","article-title":"IGF-1 protects against diabetic features in an in vivo model of Huntington's disease","volume":"231","author":"Duarte","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.npep.2016.01.009_bb0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.expneurol.2011.05.024","article-title":"Bioenergetic dysfunction in Huntington's disease human cybrids","volume":"231","author":"Ferreira","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.npep.2016.01.009_bb0055","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/1097-4547(20000615)60:6<779::AID-JNR10>3.0.CO;2-M","article-title":"Proton magnetic resonance spectroscopy of cerebrospinal fluid in neurodegenerative disease: indication of glial energy impairment in Huntington chorea, but not Parkinson disease","volume":"60","author":"G\u00e5rseth","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.npep.2016.01.009_bb0060","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","article-title":"Mechanisms of neurodegeneration in Huntington's disease","volume":"27","author":"Gil","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.npep.2016.01.009_bb0065","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","article-title":"Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice","volume":"12","author":"Gines","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.npep.2016.01.009_bb0070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature01298","article-title":"IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice","volume":"421","author":"Holzenberger","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.npep.2016.01.009_bb0075","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1534-5807(02)00188-0","article-title":"The IGF-1\/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt","volume":"2","author":"Humbert","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.npep.2016.01.009_bb0080","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neulet.2014.07.049","article-title":"Heterozygous Igf1r deletion does not ameliorate pathological features associated with polyglutamine-containing huntingtin fragment","volume":"580","author":"Jakubik","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2016.01.009_bb0085","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","article-title":"Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy","volume":"43","author":"Jenkins","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.npep.2016.01.009_bb0090","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/WNL.50.5.1357","article-title":"1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers","volume":"50","author":"Jenkins","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.npep.2016.01.009_bb0095","article-title":"Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendrocrine mechanism","volume":"6","author":"Kapperler","year":"2008","journal-title":"PLoS Biol."},{"issue":"6454","key":"10.1016\/j.npep.2016.01.009_bb0100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/366461a0","article-title":"A C. elegans mutant that lives twice as long as wild type","volume":"366","author":"Kenyon","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.npep.2016.01.009_bb0105","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.410410206","article-title":"Energy metabolism defects in Huntington's disease and effects of coenzyme Q10","volume":"41","author":"Koroshetz","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.npep.2016.01.009_bb0110","first-page":"1777","article-title":"Creatine phosphate","volume":"4","author":"Lamprecht","year":"1974"},{"key":"10.1016\/j.npep.2016.01.009_bb0115","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nbd.2013.06.002","article-title":"Enhanced Ca(2+)-dependent glutamate release from astrocytes of the BACHD Huntington's disease mouse model","volume":"58","author":"Lee","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.npep.2016.01.009_bb0120","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/1531-8249(200007)48:1<72::AID-ANA11>3.0.CO;2-I","article-title":"Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropal-lidoluysian atrophy","volume":"48","author":"Lodi","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.npep.2016.01.009_bb0125","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s12035-013-8585-5","article-title":"IGF-1 intranasal administration rescues Huntington's disease phenotypes in YAC128 mice","volume":"49","author":"Lopes","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.npep.2016.01.009_bb0130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jns.2007.05.035","article-title":"Is brain lactate increased in Huntington's disease?","volume":"263","author":"Martin","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.npep.2016.01.009_bb0135","doi-asserted-by":"crossref","first-page":"30773","DOI":"10.1074\/jbc.M504749200","article-title":"Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin","volume":"280","author":"Milakovic","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2016.01.009_bb0140","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1074\/jbc.M111.309849","article-title":"Early alterations of brain cellular energy homeostasis in Huntington's disease models","volume":"287","author":"Mochel","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2016.01.009_bb0145","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.152161099","article-title":"The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans","volume":"99","author":"Morley","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.npep.2016.01.009_bb0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1515\/rns.2011.060","article-title":"Mitochondrial and metabolic-based protective strategies in Huntington's disease: the case of creatine and coenzyme Q","volume":"23","author":"Naia","year":"2011","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.npep.2016.01.009_bb0155","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12035-014-8735-4","article-title":"Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's disease human lymphoblasts","volume":"51","author":"Naia","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.npep.2016.01.009_bb0160","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1074\/mcp.M500090-MCP200","article-title":"Proteomic analysis of protein expression and oxidative modification in R6\/2 transgenic mice: a model of Huntington disease","volume":"4","author":"Perluigi","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.npep.2016.01.009_bb0165","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/hmg\/ddq026","article-title":"Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression","volume":"19","author":"Pouladi","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.npep.2016.01.009_bb0170","doi-asserted-by":"crossref","first-page":"12347","DOI":"10.3390\/s120912347","article-title":"Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays","volume":"12","author":"Rampersad","year":"2012","journal-title":"Sensors (Basel)"},{"key":"10.1016\/j.npep.2016.01.009_bb0175","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1210\/endo-107-5-1451","article-title":"Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins","volume":"107","author":"Rechler","year":"1980","journal-title":"Endocrinology"},{"key":"10.1016\/j.npep.2016.01.009_bb0180","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.freeradbiomed.2014.06.023","article-title":"Insulin and IGF-1 improve mitochondrial function in a PI-3K\/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells","volume":"74","author":"Ribeiro","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.npep.2016.01.009_bb0185","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1212\/01.wnl.0000174432.87383.87","article-title":"Regional cortical thinning in preclinical Huntington disease and its relationship to cognition","volume":"65","author":"Rosas","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.npep.2016.01.009_bb0190","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pharmthera.2005.04.008","article-title":"The therapeutic role of creatine in Huntington's disease","volume":"108","author":"Ryu","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.npep.2016.01.009_bb0195","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1172\/JCI46305","article-title":"IRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease","volume":"121","author":"Sadagursky","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.npep.2016.01.009_bb0200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/WNL.0b013e3181e62076","article-title":"High insulin like growth factor I is associated with cognitive decline in Huntington disease","volume":"75","author":"Saleh","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.npep.2016.01.009_bb0205","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","article-title":"HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism","volume":"14","author":"Seong","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.npep.2016.01.009_bb0210","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.mito.2013.05.006","article-title":"Mitochondrial respiratory chain complex activity and bioenergetic alterations in human platelets derived from pre-symptomatic and symptomatic Huntington's disease carriers","volume":"13","author":"Silva","year":"2013","journal-title":"Mitochondrion"},{"key":"10.1016\/j.npep.2016.01.009_bb0215","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.npep.2016.01.009_bb0220","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0003-2697(85)90405-1","article-title":"Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells","volume":"146","author":"Stocchi","year":"1985","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.npep.2016.01.009_bb0225","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/1531-8249(200001)47:1<80::AID-ANA13>3.0.CO;2-K","article-title":"Mitochondrial dysfunction and free radical damage in the Huntington R6\/2 trans- genic mouse","volume":"47","author":"Tabrizi","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.npep.2016.01.009_bb0230","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1093\/hmg\/ddr203","article-title":"Neuron-specific proteotoxicity of mutant ataxin-3 in C. elegans: rescue by the DAF-16 and HSF-1 pathways","volume":"20","author":"Teixeira-Castro","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.npep.2016.01.009_bb0235","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","article-title":"Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells","volume":"9","author":"Trettel","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.npep.2016.01.009_bb0240","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1021\/pr050244o","article-title":"Metabolic characterization of the R6\/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy","volume":"5","author":"Tsang","year":"2006","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.npep.2016.01.009_bb0245","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.npep.2016.01.009_bb0250","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.20101470","article-title":"Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme","volume":"208","author":"Wolf","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.npep.2016.01.009_bb0255","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2174\/18715273113126660141","article-title":"The role of neuronal insulin\/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications","volume":"13","author":"Zemva","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.npep.2016.01.009_bb0260","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1471-4159.2007.04957.x","article-title":"c-Jun N-terminal kinase regulates mitochondrial bioenergetics by modulating pyruvate dehydrogenase activity in primary cortical neurons","volume":"104","author":"Zhou","year":"2008","journal-title":"J. Neurochem."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417916000172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417916000172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T03:51:33Z","timestamp":1718337093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417916000172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":52,"alternative-id":["S0143417916000172"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2016.01.009","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2016.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}